RESUMEN
ABSTRACT We present an interesting case of a 62-year-old black female, presented to the ophthalmological hospital with a little "nevus" on the left eye previously visualized at the mirror, with one month of development. Physical examination with slit lamp (biomicroscopy) showed a group of painless veins, with vascular redness, and a mass nodular aspect in the mid temporal bulbar conjunctiva, of approximately 2mmx4mm.
RESUMO Apresentamos o interessante caso de uma mulher negra de 62 anos, que deu entrada no hospital oftalmológico com um pequeno nevo no olho esquerdo previamente visualizado ao espelho, com 1 mês de evolução. O exame físico com lâmpada de fenda (biomicroscopia) mostrou um grupo de veias indolor e vermelhidão vascular, com uma massa de aspecto nodular na conjuntiva bulbar temporal média, de aproximadamente 2mmx4mm.
Asunto(s)
Humanos , Femenino , Persona de Mediana Edad , Sarcoma de Kaposi/diagnóstico , Sarcoma de Kaposi/etiología , Infecciones por VIH/complicaciones , Infecciones por VIH/diagnóstico , Neoplasias del Ojo/diagnóstico , Neoplasias del Ojo/etiología , Sarcoma de Kaposi/cirugía , Infecciones por Treponema/diagnóstico , Biopsia , Infecciones por VIH/tratamiento farmacológico , Seropositividad para VIH , Neoplasias del Ojo/cirugía , Microscopía con Lámpara de HendiduraRESUMEN
In 1967, Sandy Posey pronounced that sunglasses are essential beachwear ( https://www.youtube.com/watch?v=4HVBEb-GA1Y ). Now, whole-genome sequencing reveals that ultraviolet radiation (UVR) can contribute to melanomas in the iris and conjunctiva, data that provide a molecular explanation for why it is important to protect our eyes from exposure to UVR.
Asunto(s)
Neoplasias del Ojo/prevención & control , Melanoma/prevención & control , Rayos Ultravioleta/efectos adversos , Neoplasias del Ojo/etiología , Neoplasias del Ojo/genética , Dispositivos de Protección de los Ojos , Redes Reguladoras de Genes/efectos de la radiación , Humanos , Melanoma/etiología , Melanoma/genética , Secuenciación Completa del GenomaRESUMEN
INTRODUCTION: The immunosuppressive efficiency obtained in the last decades in kidney transplantation significantly improved graft survival. However, there is still a high risk and incidence of cancer in transplant patients strongly and directly related to the type of immunosuppression. An increasing body of evidence suggests that the PI3K/Akt/mTOR pathway may play a pivotal role in the development and progression of several neoplastic diseases. CASE PRESENTATION: We describe a 47-year-old male patient who received a cadaveric primary renal transplant in November 2008 developing a poorly differentiated infiltrating and ulcerated squamous cell carcinoma (SCC) at the eye level. In this patient, the modification of an immunosuppressive regimen with introduction of rapamycin (mTOR) inhibitors and withdrawal of calcineurin inhibitors (CNIs) led to the resolution of this severe condition. CONCLUSION: The introduction of mTOR inhibitors and withdrawal of CNIs in kidney-transplanted patients with de novo eye SCC should be considered in this clinical setting.
Asunto(s)
Inhibidores de la Calcineurina/efectos adversos , Carcinoma de Células Escamosas/etiología , Neoplasias del Ojo/etiología , Inmunosupresores/efectos adversos , Trasplante de Riñón/efectos adversos , Sirolimus/antagonistas & inhibidores , Antineoplásicos/uso terapéutico , Carcinoma de Células Escamosas/tratamiento farmacológico , Everolimus/uso terapéutico , Neoplasias del Ojo/tratamiento farmacológico , Humanos , Trasplante de Riñón/métodos , Masculino , Persona de Mediana Edad , Serina-Treonina Quinasas TOR/antagonistas & inhibidoresAsunto(s)
Carcinoma de Células Escamosas/etiología , Enfermedad de Crohn/complicaciones , Neoplasias del Ojo/etiología , Antiinflamatorios no Esteroideos/uso terapéutico , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/cirugía , Enfermedad de Crohn/diagnóstico , Enfermedad de Crohn/tratamiento farmacológico , Neoplasias del Ojo/patología , Neoplasias del Ojo/cirugía , Glucocorticoides/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Resultado del TratamientoRESUMEN
Nasopharyngeal carcinoma (NPC) has a distinctive geographical distribution in China, especially southern China. There are several risk factors for NPC, such as Epstein-Barr virus, genetics, and environmental exposures. Although the incidence of eye metastasis (EM) is lower than metastasis in other body parts, it often indicates poor prognosis.We assessed several serum biomarkers for their ability to predict EM in NPC. Patients with NPC were selected (nâ=â963), and were separated into two groups, EM and no eye metastasis. Ten factors were analyzed in both groups including triglyceride (TG), high-density lipoprotein, low-density lipoprotein, alkaline phosphatase, alpha fetoprotein, carbohydrate antigen-199, cancer antigen-153, apolipoproteins AI, apolipoprotein B, and cytokeratin fragment 19 (CYFRA21-1). Independent t tests, binary logistic regression, and receiver operating characteristic curves were used to assess the data.The EM group had significantly higher CYFRA21-1 and lower TG compared with the no eye metastasis group. Areas under the curve for CYFRA21-1, TG and CYFRA21-1/TG were 0.966, 0.771, and 0.976, respectively. The corresponding cut-off values were 12.12âng/ml, 0.41âmmol/L, and 13.5. The sensitivity and specificity of CYFRA21-1/TG were 100% and 92.2%, respectively.The increased ratio of CYFRA21-1 to TG can be an accurate method to detect EM in patients with NPC.
Asunto(s)
Antígenos de Neoplasias/análisis , Neoplasias del Ojo/etiología , Queratina-19/análisis , Neoplasias Nasofaríngeas/genética , Metástasis de la Neoplasia/diagnóstico , Tiroglobulina/análisis , Adulto , Antígenos de Neoplasias/sangre , Biomarcadores de Tumor/análisis , China/epidemiología , Neoplasias del Ojo/epidemiología , Neoplasias del Ojo/genética , Femenino , Humanos , Queratina-19/sangre , Modelos Logísticos , Masculino , Persona de Mediana Edad , Neoplasias Nasofaríngeas/epidemiología , Metástasis de la Neoplasia/diagnóstico por imagen , Metástasis de la Neoplasia/fisiopatología , Factores de Riesgo , Sensibilidad y Especificidad , Tiroglobulina/sangreRESUMEN
BACKGROUND: Ocular surface squamous neoplasia (OSSN) is the most common ocular surface tumour. Diagnosis and management have traditionally been by excision biopsy. Recently there has been success with the use of topical chemo or immunotherapy, which has resulted in a move from invasive diagnosis by histology to an array of non-invasive diagnostic tests. METHODS: This observational study aims to describe the characteristics of patients with OSSN at St John Eye Hospital in Johannesburg, South Africa. Non-invasive diagnostic tests (impression cytology, anterior segment-OCT, methylene blue staining) will be compared to the gold standard, histology. Treatment success, recurrence and adverse events will be documented between three treatment options that include: surgical excision, topical 5-Fluorouracil (5FU) chemotherapy, and topical 5FU with retinoic acid therapy. DISCUSSION: There is a trend to the use of less invasive diagnosis and management for OSSN. Minimally invasive diagnostic tests include cytology, anterior-segment OCT and methylene blue staining. The study will compare these to the gold standard histology, thereby providing evidence for their use in clinical practice. Interferon alpha 2b is commonly used as immunotherapy for OSSN. The cost of this medication is prohibitive to its adoption in a developing country. We therefore decided to use 5FU as the chemotherapeutic agent of choice in this study. The success, adverse events and recurrence rates with this agent may provide additional evidence for its use in the management of OSSN. Overall, if diagnosis and management can be implemented with good success in the outpatient environment, care can be improved for this condition in a developing country.
Asunto(s)
Carcinoma de Células Escamosas/diagnóstico , Neoplasias del Ojo/diagnóstico , Adulto , Antineoplásicos/uso terapéutico , Área Bajo la Curva , Carcinoma de Células Escamosas/tratamiento farmacológico , Carcinoma de Células Escamosas/etiología , Neoplasias del Ojo/tratamiento farmacológico , Neoplasias del Ojo/etiología , Femenino , Fluorouracilo/uso terapéutico , Humanos , Inmunoterapia , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia , Curva ROC , Factores de Riesgo , Sudáfrica , Centros de Atención Terciaria , Tomografía de Coherencia Óptica , Resultado del Tratamiento , Rayos Ultravioleta/efectos adversosRESUMEN
BACKGROUND Xeroderma pigmentosum (XP) is an autosomal recessive disease caused by mutations in DNA repair genes. Clinical manifestations include extreme sensitivity to ultraviolet (UV) rays, freckle-like pigmentation, ocular abnormalities, and an increased risk of developing neoplasms in sun-exposed areas of the skin, mucous membranes, and eyes. This paper describes the clinical outcome of pegylated interferon alpha 2b (PEG-IFN-alpha-2b) subconjunctival injections and topical mitomycin C (MMC) in the treatment of ocular surface squamous neoplasia (OSSN) in patients with XP. CASE REPORT A series of 3 patients with histopathologically-proven biopsy specimens of XP-associated neoplasia of the eyelids and ocular surface underwent subconjunctival injections of PEG-IFN-alpha-2 band topical cycles of MMC. There was a noticeable decrease in the size and severity of ocular surface squamous neoplasia, with minimal adverse effects of flu-like symptoms with mild fever and generalized malaise. Transient mental depression was reported in 2 of our patients, and only 1 patient developed autoimmune diabetes mellitus, which required insulin therapy after the discontinuation of the PEG-IFN-alpha-2b. CONCLUSIONS The literature on the specifics of ocular care using PEG-IFN-alpha-2b for XP-associated OSSN is sparse. However, according to our clinical experience, the combination of PEG-IFN-alpha-2b subconjunctival injection and the topical cycles of MMC is a promising long-term medical therapy to minimize the development and recurrence of OSSN in XP patients.
Asunto(s)
Carcinoma de Células Escamosas/tratamiento farmacológico , Neoplasias del Ojo/tratamiento farmacológico , Interferón alfa-2/uso terapéutico , Interferón-alfa/uso terapéutico , Mitomicina/uso terapéutico , Polietilenglicoles/uso terapéutico , Xerodermia Pigmentosa/complicaciones , Adulto , Antibióticos Antineoplásicos/uso terapéutico , Antivirales/uso terapéutico , Carcinoma de Células Escamosas/etiología , Quimioterapia Combinada , Neoplasias del Ojo/etiología , Femenino , Humanos , Masculino , Proteínas Recombinantes/uso terapéuticoRESUMEN
Bladder cancer is a common type of tumor among elderly male population; it causes intraocular metastasis (IOM). The study investigated the differences between elderly male bladder cancer patients with and without IOM, and identified risk factors for IOM. In this study, 749 elderly male patients (aged ≥50 years) with bladder cancer were included from November 2003 to December 2016. Differences between the IOM and non-IOM (NIOM) groups were evaluated by chi-square test and Student's t-test. The binary logistic regression analysis calculates the risk factors. Receiver operating characteristic (ROC) curve analysis was used to assess the diagnostic value of IOM in elderly male patients with bladder cancer. The incidence of IOM in patients with bladder cancer was 1.7%. No significant differences were detected in age and histopathology between the IOM and NIOM groups. According to the study, the IOM group had higher ALP and Cyfra21-1. Binary logistic regression indicated that ALP and Cyfra21-1 were risk factors for IOM in elderly male bladder cancer patients (p < .05). ROC curve analysis revealed area under the curve values for ALP and Cyfra21-1 of 0.913 and 0.814, using cutoff values of 9.65 and 83.5 U/L, respectively. The sensitivity and specificity values for ALP were 61.5% and 95.8%, respectively, while those for Cyfra21-1 were 84.6% and 73.3%. The investigation indicates that ALP and Cyfra21-1 are risk factors for IOM in elderly male patients with bladder cancer and ALP is more reliable at distinguishing IOM from NIOM in elderly male patients with bladder cancer.
Asunto(s)
Neoplasias del Ojo/secundario , Neoplasias de la Vejiga Urinaria/patología , Anciano , Neoplasias del Ojo/etiología , Humanos , Modelos Logísticos , Masculino , Registros Médicos , Persona de Mediana Edad , Factores de RiesgoRESUMEN
Primary central nervous system lymphoma (PCNSL) may manifest initially in the eye (termed vitreoretinal lymphoma or VRL) or in non-ocular CNS compartments, or in both. The nature of the onset of PCNSL implies two clinical specialists - ophthalmologists and neuro-oncologists - independently may assess the primary presentation of this rare malignancy. Clinically relevant perspectives on expectations of PCNSL manifestation in both ocular and non-ocular CNS compartments would help inform management practices in each specialty, which should impact clinical outcomes. A recent increase in the number of published PCNSL cohort studies provides new opportunity to review the current prevalence rates of ocular involvement, and the timing of this involvement over the course of disease. In PCNSL cohorts defined by non-ocular CNS compartment involvement, with or without ocular involvement (termed "PCNSL ± ocular involvement" cohorts), mean rates of concomitant VRL at diagnosis, or at any time during the course, are 10% and 16%, respectively. Only a few individuals within this cohort group present with exclusive eye disease (<5%), and the rate of secondary ocular involvement is only 5-9%. In PCNSL cohorts defined by the involvement of the ocular compartment, with or without non-ocular CNS involvement (termed "VRL ± non-ocular CNS involvement" cohorts), 58% of persons have a primary ocular diagnosis, which carries a 50% risk of secondary involvement in the CNS beyond the eye. Rates of non-ocular CNS involvement with VRL at diagnosis or over the course of disease are 41% and 69%, respectively.
Asunto(s)
Neoplasias del Sistema Nervioso Central/complicaciones , Neoplasias del Ojo/etiología , Linfoma/complicaciones , Retina/patología , Cuerpo Vítreo/patología , Neoplasias del Ojo/epidemiología , Salud Global , Humanos , PrevalenciaRESUMEN
The purpose of the study was to investigate the association between infectious agents and the development of cancer in the ocular adnexa. A comprehensive literary study was carried out, reviewing and summarizing previous reports on the topic. A broad range of malignancies of the ocular adnexa are associated with infectious agents. A strong association and possible causal relationship between the infectious agent and the development of ocular adnexal cancer are seen in Merkel cell carcinoma (Merkel cell polyomavirus), Burkitt lymphoma (Epstein-Barr virus) and Kaposi sarcoma (human herpesvirus 8). Infection with Chlamydia psittaci has been associated with the development of extranodal marginal zone B-cell lymphoma in Italy. Human papillomavirus infection has been associated with the development of squamous cell carcinomas of the ocular adnexa, although with a highly variable reported prevalence. By exploring the role of infectious agents in the ocular adnexa and the mechanism by which they contribute to oncogenesis, the diagnostics, management and prevention of these malignancies may also improve. Antibiotic treatment and vaccines against infectious agents may be valuable in future treatment. Additionally, the presence of infectious agents within the tumours may have a prognostic or predictive value.
Asunto(s)
Enfermedades Transmisibles/complicaciones , Neoplasias del Ojo/etiología , Antibacterianos/uso terapéutico , Carcinoma de Células Escamosas/tratamiento farmacológico , Carcinoma de Células Escamosas/etiología , Carcinoma de Células Escamosas/microbiología , Carcinoma de Células Escamosas/virología , Enfermedades Transmisibles/microbiología , Enfermedades Transmisibles/virología , Neoplasias del Ojo/tratamiento farmacológico , Neoplasias del Ojo/microbiología , Neoplasias del Ojo/virología , Humanos , ItaliaAsunto(s)
Ambliopía/diagnóstico , Quiste Dermoide/diagnóstico , Neoplasias del Ojo/diagnóstico , Síndrome de Goldenhar/diagnóstico , Ambliopía/etiología , Anisometropía/diagnóstico , Anisometropía/etiología , Astigmatismo/diagnóstico , Astigmatismo/etiología , Quiste Dermoide/etiología , Encondromatosis/diagnóstico , Encondromatosis/etiología , Neoplasias del Ojo/etiología , Asimetría Facial/diagnóstico , Asimetría Facial/etiología , Síndrome de Goldenhar/complicaciones , Humanos , Lactante , MasculinoRESUMEN
BACKGROUND Encephalocraniocutaneous lipomatosis is a rare neurocutaneous disorder characterized by cutaneous, ocular, and central nervous system anomalies; its molecular etiology was recently identified. This report describes the surgical treatment and genetic characterization of a giant ocular lipodermoid cyst secondary to encephalocraniocutaneous lipomatosis. CASE REPORT An 11-year-old girl with past medical history of absence seizures presented with a reddish protruding mass in her right eye involving the temporal conjunctiva and the peripheral temporal cornea; eyelid closure was not possible due to mass protrusion. She also presented skin tags at the level of the external canthus and 3 alopecic areas at the level of the scalp compatible with nevus psiloliparus. No family history was reported. A dermoid cyst was suspected and excisional biopsy was performed under general anesthesia. A large conjunctival and lamellar corneoscleral resection was done, followed by a corneal tectonic graft. Molecular analysis was carried out, including PCR and Sanger sequencing on DNA obtained from the mass. After surgery, the patient achieved complete eyelid closure, reduction of ocular surface symptoms, and improved aesthetic appearance. Histological analysis confirmed a lipodermoid cyst; genetic tests confirmed a mosaic activating mutation in FGFR1 (c.1638C>A, p.Asn546Lys). The diagnosis was encephalocraniocutaneous lipomatosis. CONCLUSIONS ECCL is a rare condition; an accurate diagnosis comprising clinical and genetic aspects can facilitate the monitoring of possible complications, improve the multidisciplinary treatment, and provide valuable information for future therapy developments. In this case, the patient's quality of life improved significantly, ocular symptoms disappeared, and a good esthetic appearance was achieved.
Asunto(s)
Quiste Dermoide/genética , Quiste Dermoide/cirugía , Oftalmopatías/diagnóstico , Oftalmopatías/genética , Neoplasias del Ojo/genética , Neoplasias del Ojo/cirugía , Lipomatosis/diagnóstico , Lipomatosis/genética , Síndromes Neurocutáneos/diagnóstico , Síndromes Neurocutáneos/genética , Receptor Tipo 1 de Factor de Crecimiento de Fibroblastos/genética , Biopsia , Niño , Trasplante de Córnea , Análisis Mutacional de ADN , Quiste Dermoide/etiología , Oftalmopatías/complicaciones , Neoplasias del Ojo/etiología , Femenino , Humanos , Lipomatosis/complicaciones , Síndromes Neurocutáneos/complicaciones , Reacción en Cadena de la Polimerasa , Convulsiones/etiologíaRESUMEN
Over the last few years, we have seen constant development of molecular pathology for the care of patients with cancer. The information obtained from molecular data has transformed our thinking about the biological diversity of cancers, particularly in the field of ophthalmic oncology. It has reoriented the way in which therapeutic decisions and decisions concerning patient surveillance are made, both in the area of pediatric cancers, including rhabdomyosarcoma and retinoblastoma, and adult cancers, such as uveal melanoma and lymphomas. A better definition of the molecular classification of these cancers and of the different biological pathways involved is essential to the understanding of both the pathologist and the onco-ophthalmologist. Molecular tests based on targeted or expanded analysis of gene panels are now available. These tests can be performed with tumor tissue or biofluids (especially blood) to predict the prognosis of tumors and, above all, the benefit of targeted therapies, immunotherapy or even chemotherapy. Looking for the BAP1 mutation in uveal melanoma is essential because of the associated metastatic risk. When treating retinoblastoma, it is mandatory to assess the heritable status of RB1. Conjunctival melanoma requires investigation into the BRAF mutation in the case of a locally advanced tumor. The understanding of genomic alterations, the results of molecular tests and/or other biological tests predictive of a therapeutic response, but also of the limits of these tests with respect to the available biological resources, represents a major challenge for optimal patient management in ophthalmic oncology. In this review, we present the current state of knowledge concerning the different molecular alterations and therapeutic targets of interest in ophthalmic oncology.
Asunto(s)
Neoplasias del Ojo/diagnóstico , Patología Molecular/métodos , Animales , Biomarcadores de Tumor , Diagnóstico Diferencial , Susceptibilidad a Enfermedades , Neoplasias del Ojo/etiología , Neoplasias del Ojo/terapia , Humanos , Técnicas de Diagnóstico Molecular , Clasificación del Tumor , Estadificación de Neoplasias , Fenotipo , PigmentaciónRESUMEN
Large cysts in the orbital lobe of the lacrimal gland are rare and are associated with Sjögren syndrome and B-cell mucosa-associated lymphoid tissue lymphoma. The authors describe 4 new cases of large orbital lobe lacrimal gland cysts. The first 2 patients, both with Sjögren syndrome, had unilateral cysts associated with chronic inflammation. Mucosa-associated lymphoid tissue lymphoma was also identified in the cyst wall of the second case and could not be completely excluded in the first case. The third patient, with a history of rheumatoid arthritis, had bilateral cysts, again associated with mucosa-associated lymphoid tissue lymphoma. The fourth patient, with no history of systemic disease, had a unilateral cyst associated with reactive lymphoid hyperplasia. Finally, the authors report the long-term outcomes of 3 previously reported cases.
Asunto(s)
Enfermedades Autoinmunes/complicaciones , Quistes/etiología , Neoplasias del Ojo/etiología , Enfermedades del Aparato Lagrimal/complicaciones , Aparato Lagrimal/diagnóstico por imagen , Enfermedades Linfáticas/complicaciones , Linfoma de Células B de la Zona Marginal/complicaciones , Anciano , Enfermedades Autoinmunes/diagnóstico , Enfermedad Crónica , Quistes/diagnóstico , Neoplasias del Ojo/diagnóstico , Femenino , Estudios de Seguimiento , Humanos , Hiperplasia , Enfermedades del Aparato Lagrimal/diagnóstico , Enfermedades Linfáticas/diagnóstico , Linfoma de Células B de la Zona Marginal/diagnóstico , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Tomografía Computarizada por Rayos XRESUMEN
A 41-year-old man was diagnosed with immunoglobulin G4-related disease (IgG4-RD) in both eyelids 4 years ago and exhibited good response to steroid therapy. However, rapid swelling of the right eyelid lesion was recently observed. As IgG4-RD progression was suspected, biopsy was performed. Although the histology was consistent with IgG4-RD, the infiltrating large atypical lymphoid cells showed immunoglobulin light-chain restriction and IgH gene rearrangement. Consequently, he was diagnosed with extranodal marginal zone lymphoma with abundant IgG4-positive cells.
Asunto(s)
Neoplasias del Ojo , Párpados/patología , Glucocorticoides/uso terapéutico , Enfermedad Relacionada con Inmunoglobulina G4 , Linfoma de Células B de la Zona Marginal , Adulto , Biopsia/métodos , Diagnóstico Diferencial , Neoplasias del Ojo/diagnóstico , Neoplasias del Ojo/etiología , Neoplasias del Ojo/patología , Humanos , Inmunoglobulina G/análisis , Enfermedad Relacionada con Inmunoglobulina G4/complicaciones , Enfermedad Relacionada con Inmunoglobulina G4/diagnóstico , Enfermedad Relacionada con Inmunoglobulina G4/tratamiento farmacológico , Linfoma de Células B de la Zona Marginal/diagnóstico , Linfoma de Células B de la Zona Marginal/etiología , Linfoma de Células B de la Zona Marginal/patología , Masculino , Proteínas OncogénicasRESUMEN
Xeroderma pigmentosum (XP) is a form of general dermatosis characterised by photo-induced cutaneous-ocular impairment and by skin cancers. In addition to these signs, there may also be neurological involvement. This disease is related to a defect in genes within the nucleotide excision repair system for the first seven genetic groups (A-G), and to an abnormality in transcription groups for the eighth group (xeroderma pigmentosum variant - XPV). Cutaneous carcinomas are the most common types of cancer seen. They may begin in childhood. Multiple melanoma commonly occurs during the course of XP but given the frequency of spontaneous regression, the incidence is underestimated. The clinical appearance is characterised by polymorphous lesions with characteristic dyschromia and in most cases it is sufficient to establish the diagnosis. Investigation of unscheduled DNA synthesis (UDS) and cell survival following ultraviolet (UV) radiation were formerly considered the reference examination for laboratory diagnosis. However, these tests are now being replaced by new molecular biology techniques to screen for the genetic mutations characteristic of the disease. These techniques have proved extremely useful in identifying heterozygous patients and in antenatal diagnosis. Photoprotection is the key preventive measure: patients must avoid all exposure to the sun and to artificial sources of UV radiation. The therapeutic arsenal has recently been enriched by several modern therapeutic methods used to destroy cutaneous tumours such as imiquimod and photodynamic therapy (PDT). These approaches are valuable since they eliminate incipient tumours while sparing healthy skin. Surgery and cryosurgery are the most suitable methods for treating cutaneous tumours in children. Chemotherapy may be considered an alternative for the treatment of keratoacanthomas and squamous cell carcinomas (SCC). Cryosurgery may be combined with other therapeutic approaches to eliminate SCC of the lip. Management of these patients in reference centres, coupled with assistance from associations providing support for patients' families, has resulted in improved quality of therapy while slowing down disease progression.
Asunto(s)
Neoplasias Cutáneas , Xerodermia Pigmentosa , Neoplasias del Ojo/etiología , Predisposición Genética a la Enfermedad , Humanos , Neoplasias Inducidas por Radiación/genética , Neoplasias Inducidas por Radiación/terapia , Enfermedades del Sistema Nervioso/etiología , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/genética , Neoplasias Cutáneas/terapia , Luz Solar/efectos adversos , Rayos Ultravioleta/efectos adversos , Xerodermia Pigmentosa/diagnóstico , Xerodermia Pigmentosa/genética , Xerodermia Pigmentosa/terapiaRESUMEN
OBJECTIVES: The number of enucleations and visual sequels due to retinoblastoma is high. The aim of this study was to evaluate the different diagnostic aspects and propose strategies that might improve the clinical management of this condition. METHOD: A retrospective study was conducted on 38 patients with retinoblastoma studied genetically (29 unilateral, 9 bilateral). The evaluation included: age of onset, clinical signs, and time since onset, number of enucleations, time to diagnosis, and survival at 5 years. RESULTS: Leukocoria was the main clinical sign (present in 90% of cases). The mean diagnostic delay was 3.2 months. Among the unilateral cases, the eyes were enucleated in 76%, and 55% in the bilateral forms. Only one death was found among the 25 patients followed-up for at least 5 years. CONCLUSIONS: Retinoblastoma diagnostic and treatment strategies need to be updated. Good coordination between paediatricians and ophthalmologists is essential for this. Its management in reference centres, which have the necessary technology and experience, should contribute to increase the rate of organ preservation.